| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_130efb8ab1446af2ced47bb5f1b4b789 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 |
| filingDate |
2018-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6ca3b93af3d63be6c6053ef303bf421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6150806d38478fab3e93eec86582afe6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31125a3d222e8dec270328587aa09de2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7953c60ba413274b6ab2d9030c275c5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a895df6b035adcfcc6692c314966ee62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c291e580d334efebd379e7a755be338 |
| publicationDate |
2020-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111386119-A |
| titleOfInvention |
Powder formulation for nasal administration |
| abstract |
The invention prepares a powder preparation for nasal administration, which contains granular steroid hormones with an average particle diameter of 50-300 μm as active ingredients. The powder formulation for nasal administration may further contain a water-soluble polymer (especially, a water-soluble polysaccharide such as cellulose having a hydroxyalkyl group). The particulate steroid hormones may comprise or be formed from testosterone and/or derivatives thereof. The water-soluble polymer may be in granular form. The ratio of the water-soluble polymer may be about 1 to 50 parts by weight relative to 1 part by weight of the particulate steroid hormones. The powder nasal administration preparation may be a powder nasal administration preparation in which the Cmax of steroid hormones is adjusted to 15 ng/ml or less. Provided is a powder preparation for nasal administration, which can control the blood concentration of steroid hormones such as testosterone within a specific range for a long time. |
| priorityDate |
2017-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |